drugset
drugset / Trial / NCT01811082

Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia

NCT01811082 ↗

Phase 3 Completed 240 enrolled Zhejiang University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the lipid lowering effects and clinical safety of a natural hypolipidemic compound, coenzyme A capsule with a marketed drug, Pantethine Capsule, in Chinese patients with moderate dyslipidemia.

Timeline

Start
2010-07
Primary completion
2011-05
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme A Small molecule 400 mg Oral
Comparator Pantethine Small molecule 600 mg Oral

Indications

hyperlipoproteinemia